Recent clinical findings with memantine should not mean that the idea of neuroprotection in glaucoma is abandoned

Acta Ophthalmologica

Volumn 87, Issue 4, 2009, Pages 450-454

  Osborne, Neville N ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Clinical trials; Glaucoma; Memantine; Neuroprotection

Indexed keywords

MEMANTINE; NEUROPROTECTIVE AGENT;

APOPTOSIS; DRUG EFFICACY; DRUG MECHANISM; GLAUCOMA; HUMAN; NEUROPROTECTION; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RETINA GANGLION CELL; REVIEW; VISUAL IMPAIRMENT;

ADMINISTRATION, ORAL; CELL SURVIVAL; CLINICAL TRIALS, PHASE III AS TOPIC; GLAUCOMA; HUMANS; MEMANTINE; NEUROPROTECTIVE AGENTS; RETINAL GANGLION CELLS; TREATMENT FAILURE;

EID: 66249085210     PISSN: 1755375X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2008.01459.x     Document Type: Review

References (38)

1. Bezzi P, Gundersen V, Galbete JL, Seifert G, Steinhäuser C, Pilati E Volterra A (2004 Astrocytes contain a vesicular compartment that is competent for regulated exocytosis of glutamate. Nat Neurosci 7 : 613 620. (Pubitemid 38691900)
2. Boland MV Quigley HA (2007 Risk factors and open-angle glaucoma: classification and application. J Glaucoma 16 : 406 418. (Pubitemid 46945541)
3. Bormann J (1989 Memantine is a potent blocker of N-methyl-d-aspartate (NMDA) receptor channels. Eur J Pharmacol 166 : 591 592. (Pubitemid 19195356)
4. Brooks DE, Garcia GA, Dreyer EB, Zurakowski D Franco-Bourland RE (1997 Vitreous body glutamate concentration in dogs with glaucoma. Am J Vet Res 58 : 864 867. (Pubitemid 127470799)
5. Chen HS Lipton SA (2006 The chemical biology of clinically tolerated NMDA receptor antagonists. J Neurochem 97 : 1611 1626. (Pubitemid 43873656)
6. Chen H-SV, Pellegrini JW, Aggarwal SW, Lei SZ, Warach S, Jensen FE Lipton SA (1992 Open-channel block of N-methyl-d-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 12 : 4427 4436.
7. Clarke G, Collins RA, Leavitt BR, Andrews DF, Hayden MR, Lumsden CJ McInnes RR (2000 A one-hit model of cell death in inherited neuronal degenerations. Nature 406 : 195 199. (Pubitemid 30469003)
8. Clarke G, Lumsden CJ McInnes RR (2001 Inherited neurodegenerative diseases: the one-hit model of neurodegeneration. Hum Mol Genet 10 : 2269 2275. (Pubitemid 32998841)
9. Ditzler K (1991 Efficacy and tolerability of memantine in patients with dementia syndrome. A double-blind, placebo controlled trial. Arzneim.-Forsch/Drug Res 41 : 773 780.
10. Dreyer EB, Zurakowski D, Schumer RA, Podos SM Lipton SA (1996 Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol 114 : 299 305. (Pubitemid 26086736)
11. Flammer J Mozaffarieh M (2007 What is the present pathogenetic concept of glaucomatous optic neuropathy? Surv Ophthalmol 52 (Suppl. 2 162 173.
12. Flammer J, Orgül S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, Renard JP Stefánsson E (2002 The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 21 : 359 393.
13. Fletcher EL, Hack I, Brandstätter JH Wässle H (2000 Synaptic localization of NMDA receptor subunits in the rat retina. J Comp Neurol 420 : 98 112. (Pubitemid 30207236)
14. Hernandez MR Pena JD (1997 The optic nerve head in glaucomatous optic neuropathy. Arch Ophthalmol 115 : 389 395. (Pubitemid 27131307)
15. Jain KK (2000 Evaluation of memantine for neuroprotection in dementia. Expert Opin Investig Drugs 9 : 1397 1406. (Pubitemid 30342623)
16. Kerrigan LA, Zack DJ, Quigley HA, Smith SD Pease ME (1997 UNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol 115 : 1031 1035. (Pubitemid 27328493)
17. Levkovitch-Verbin H, Martin KR, Quigley HA, Baumrind LA, Pease ME Valenta D (2002 Measurement of amino acid levels in the vitreous humor of rats after chronic intraocular pressure elevation or optic nerve transection. J Glaucoma 11 : 396 405.
18. Lipton SA (2007 Pathologically activated therapeutics for neuroprotection. Nat Rev Neurosci 8 : 803 808. (Pubitemid 47462118)
19. Mahesh VB, Dhandapani KM Brann DW (2006 Role of astrocytes in reproduction and neuroprotection. Mol Cell Endocrinol 246 : 1 9. (Pubitemid 43238391)
20. Mandel SA, Avramovich-Tirosh Y, Reznichenko L, Zheng H, Weinreb O, Amit T Youdim MB (2005 Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway. Neurosignals 14 : 46 60. (Pubitemid 40868983)
21. Massey SC (1990 Cell types using glutamate as a neurotransmitter in the vertebrate retina. Prog Retin Eye Res 9 : 399 425. (Pubitemid 20096528)
22. Mayer ML Westbrook GL (1987 The physiology of excitatory amino acids in the vertebrate central nervous system. Prog Neurobiol 28 : 197 276. (Pubitemid 17023404)
23. Meldrum BS (2000 Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr 130 1007 1015.
24. Osborne NN, Beale R, Golombiowska-Nikitin K Sontag K-H (1982 The effect of memantine on various neurobiological processes. Arzneim.-Forsch/Drug Res 32 : 1246 1255. (Pubitemid 12034274)
25. Osborne NN, Ugarte M, Chao M, Chidlow G, Bae JH, Wood JP Nash MS (1999 Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv Ophthalmol 43 (Suppl. 1 102 128.
26. Osborne NN, Melena J, Chidlow G Wood JP (2001 A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucoma. Br J Ophthalmol 85 : 1252 1259. (Pubitemid 32929554)
27. Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M Melena J (2004 Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res 23 : 91 147. (Pubitemid 38180539)
28. Osborne NN, Lascaratos G, Bron AJ, Chidlow G Wood JP (2006 A hypothesis to suggest that light is a risk factor in glaucoma and the mitochondrial optic neuropathies. Br J Ophthalmol 90 : 237 241. (Pubitemid 43163859)
29. Osborne NN, Li GY, Ji D, Mortiboys HJ Jackson S (2008 Light affects mitochondria to cause apoptosis to cultured cells: possible relevance to ganglion cell death in certain optic neuropathies. J Neurochem 105 : 2013 2028.
30. Pache M Flammer J (2006 A sick eye in a sick body? Systemic findings in patients with primary open-angle glaucoma. Surv Ophthalmol 51 : 179 212.
31. Parsons CG, Gruner R, Rozental J, Millar J Lodge D (1993 Patch clamp studies on the kinetics and selectivity of N-methyl-d-aspartate receptor antagonism by memantine (l-amino-3,5-dimethyladamantane). Neuropharmacology 32 : 1337 1350. (Pubitemid 24023017)
32. Quigley HA (2005 Glaucoma: macrocosm to microcosm the Friedenwald lecture. Invest Ophthalmol Vis Sci 46 : 2662 2670.
33. Salt TE Cordeiro MF (2006 Glutamate excitotoxicity in glaucoma: throwing the baby out with the bathwater? Eye 20 : 730 731. (Pubitemid 43880597)
34. Schwab RS, England AC Jr., Poskanzer DC Young RR (1969 Amantadine in the treatment of Parkinson's disease. JAMA 208 : 1168 1170.
35. Tezel G Wax MB (2000 Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J Neurosci 20 : 8693 8700.
36. Wamsley S, Gabelt BT, Dahl DB, Case GL, Sherwood RW, May CA, Hernandez MR Kaufman PL (2005 Vitreous glutamate concentration and axon loss in monkeys with experimental glaucoma. Arch Ophthalmol 123 : 64 70. (Pubitemid 40105432)
37. Winblad B Poritis N (1999 Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine). Int J Geriatr Psychiatry 14 : 135 146. (Pubitemid 29110331)
38. Zhou C Dacheux RF (2004 All amacrine cells in the rabbit retina possess AMPA-, NMDA-, GABA-, and glycine-activated currents. Vis Neurosci 21 : 181 188. (Pubitemid 38954861)